BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8778194)

  • 1. Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma.
    Noguchi O; Enomoto N; Ikeda T; Kobayashi F; Marumo F; Sato C
    J Hepatol; 1996 Mar; 24(3):286-92. PubMed ID: 8778194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hepatocyte growth factor mRNA, and c-met mRNA (hepatocyte growth factor receptor) in human liver tumours.
    Selden C; Farnaud S; Ding SF; Habib N; Foster C; Hodgson HJ
    J Hepatol; 1994 Aug; 21(2):227-34. PubMed ID: 7989714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
    Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
    Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue.
    Ljubimova JY; Petrovic LM; Wilson SE; Geller SA; Demetriou AA
    J Histochem Cytochem; 1997 Jan; 45(1):79-87. PubMed ID: 9010472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
    Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
    Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor and c-met expression in Long-Evans Cinnamon rats with spontaneous hepatitis and hepatoma.
    Nakayama N; Kashiwazaki H; Kobayashi N; Hamada JI; Ogiso Y; Itakura Y; Matsumoto K; Nakamura T; Koike T; Kuzumaki N; Takeichi N
    Hepatology; 1996 Sep; 24(3):596-602. PubMed ID: 8781331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
    Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
    Sakata H; Takayama H; Sharp R; Rubin JS; Merlino G; LaRochelle WJ
    Cell Growth Differ; 1996 Nov; 7(11):1513-23. PubMed ID: 8930401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
    Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
    Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
    Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the c-met protooncogene in human hepatocellular carcinoma.
    Suzuki K; Hayashi N; Yamada Y; Yoshihara H; Miyamoto Y; Ito Y; Ito T; Katayama K; Sasaki Y; Ito A
    Hepatology; 1994 Nov; 20(5):1231-6. PubMed ID: 7927256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation.
    Ljubimova JY; Petrovic LM; Arkadopoulos N; Blanc P; Geller SA; Demetriou AA
    Dig Dis Sci; 1997 Aug; 42(8):1675-80. PubMed ID: 9286233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.
    Daveau M; Scotte M; François A; Coulouarn C; Ros G; Tallet Y; Hiron M; Hellot MF; Salier JP
    Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepatocyte growth factor in human hepatocellular carcinoma.
    Guirouilh J; Le Bail B; Boussarie L; Balabaud C; Bioulac-Sage P; Desmoulière A; Schuppan D; Rosenbaum J
    J Hepatol; 2001 Jan; 34(1):78-83. PubMed ID: 11211911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats.
    Inoue H; Yokoyama F; Kita Y; Yoshiji H; Tsujimoto T; Deguchi A; Nakai S; Morishita A; Uchida N; Masaki T; Watanabe S; Kuriyama S
    Int J Mol Med; 2006 May; 17(5):857-64. PubMed ID: 16596271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.
    Corpechot C; Barbu V; Wendum D; Chignard N; Housset C; Poupon R; Rosmorduc O
    Am J Pathol; 2002 Feb; 160(2):613-20. PubMed ID: 11839582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transforming growth factor-alpha mRNA in livers of patients with chronic viral hepatitis and hepatocellular carcinoma.
    Chung YH; Kim JA; Song BC; Lee GC; Koh MS; Lee YS; Lee SG; Suh DJ
    Cancer; 2000 Sep; 89(5):977-82. PubMed ID: 10964327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.
    Ang CS; Sun MY; Huitzil-Melendez DF; Chou JF; Capanu M; Jarnagin W; Fong Y; Dematteo RP; D'Angelica M; Allen P; Chen CT; O'Reilly EM; Weiser MR; Abou-Alfa GK
    Anticancer Res; 2013 Aug; 33(8):3241-5. PubMed ID: 23898085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.